Delivery Order SPE2DB22D3301-SPE2DB25FY8BE
- Not listed
- The Defense Logistics Agency awarded a $3,744.69 delivery order to AmerisourceBergen Drug Corp for Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials, with an ultimate completion date of August 12, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will fulfill this order through its corporate office division. This...
- The Defense Logistics Agency awarded a $10,332.55 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials under a firm fixed-price contract. The award, issued on August 1, 2025, carries an ultimate completion date of August 4, 2025, and represents a non-competitive set-aside delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office...
- The Defense Logistics Agency awarded a $28,959.78 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract with no set-aside utilizes AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,660.86 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by July 24, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,904.98 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL formulations. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, with a completion date of July 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its corporate office location in the same city....
- The Defense Logistics Agency awarded a $5,910.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This award, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, the location of...
- The Defense Logistics Agency awarded a delivery order valued at $41,046.84 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded and scheduled for completion by July 28, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,246.87 to AmerisourceBergen Drug Corp for Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents a non-set-aside competitive award. The medication will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,004.33 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. This competitive award, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed-price transaction with no set-aside designation. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters and a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials, with a ceiling value of $18,294.14. This competitively awarded, firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY8BEDelivery Order
The Defense Logistics Agency awarded a $4,177.64 delivery order to AmerisourceBergen Drug Corp for Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials under a firm fixed-price contract, with an ultimate completion date of July 21, 2025. This award represents a non-set-aside, competitively awarded delivery order executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare systems globally. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location and deliver the diabetes medication as part of its comprehensive role supporting federal medical procurement needs for the Department of Defense. This delivery order reflects AmerisourceBergen's established capability in the Pharmaceutical Prime Vendor program, which encompasses a broad portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The contract demonstrates the company's continued role as a critical vendor for military healthcare systems, including the Defense Health Agency and U.S. Coast Guard, through its flexible and extensive contract vehicle that enables rapid procurement of essential pharmaceutical commodities to support ongoing military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 7/18/25 |